Cardiovascular effects of Hodgkin's lymphoma: a review of literature
- PMID: 29255934
- PMCID: PMC11813374
- DOI: 10.1007/s00432-017-2560-x
Cardiovascular effects of Hodgkin's lymphoma: a review of literature
Abstract
Hodgkin's lymphoma (HL) constitutes 0.6% of all the cancers diagnosed worldwide and 10% of all lymphomas. Ten-year survival rate for HL is estimated to be 80% and cardiovascular death is the prevalent cause for a non-malignant death among these HL survivors. We are reviewing the cardiovascular morbidities associated with Hodgkin's lymphoma from the available literature. We performed a systematic review of all articles published from January 1, 1960 to October 1, 2016 on the MEDLINE database using PubMed search engine. Key factors in the diagnosis and management of these conditions are discussed in individual sections.
Keywords: Cancer; Cardiac; Cardiology; Cardiovascular; Chemotherapy; Complications; Hodgkin’s lymphoma; Lymphoma; Malignancy; Radiation; Treatment.
Conflict of interest statement
None.
Figures
References
-
- Adler Y, Charron P, Imazio M et al (2015) European Society of Cardiology (ESC) 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 36(42):2921–2964 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
